1. Home
  2. MNKD vs CRON Comparison

MNKD vs CRON Comparison

Compare MNKD & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.76

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$3.16

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
CRON
Founded
1991
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
MNKD
CRON
Price
$3.76
$3.16
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$8.69
N/A
AVG Volume (30 Days)
3.1M
1.3M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.12
Revenue
$348,966,000.00
$146,587,000.00
Revenue This Year
$35.81
$26.34
Revenue Next Year
$11.89
$15.53
P/E Ratio
N/A
$26.29
Revenue Growth
22.23
24.63
52 Week Low
$2.23
$2.28
52 Week High
$6.51
$3.61

Technical Indicators

Market Signals
Indicator
MNKD
CRON
Relative Strength Index (RSI) 41.68 48.16
Support Level $3.30 $2.49
Resistance Level $4.23 $3.28
Average True Range (ATR) 0.17 0.11
MACD -0.03 -0.04
Stochastic Oscillator 0.00 9.23

Price Performance

Historical Comparison
MNKD
CRON

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

About CRON Cronos Group Inc.

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.

Share on Social Networks: